|
1
|
Zhao Y, Wang XX, Wu W, Long H, Huang J,
Wang Z, Li T, Tang S, Zhu B and Chen D: EZH2 regulates PD-L1
expression via HIF-1α in non-small cell lung cancer cells. Biochem
Biophys Res Commun. 517:201–209. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laurans M, Botticella A, Moukasse Y, Lévy
A and Le Péchoux C: Lung cancer and elective nodal irradiation: A
solved issue? Cancer Radiother. 23:701–707. 2019.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buentzel J, Heinz J, Bleckmann A, Bauer C,
Röver C, Bohnenberger H, Saha S, Hinterthaner M, Baraki H, Kutschka
I, et al: Sarcopenia as Prognostic Factor in Lung Cancer Patients:
A Systematic Review and Meta-analysis. Anticancer Res.
39:4603–4612. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang N, Lin W, Shi X and Tao T: STK24
expression is modulated by DNA copy number/methylation in lung
adenocarcinoma and predicts poor survival. Future Oncol.
14:2253–2263. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoang LT, Domingo-Sabugo C, Starren ES,
Willis-Owen SAG, Morris-Rosendahl DJ, Nicholson AG, Cookson WOCM
and Moffatt MF: Metabolomic, transcriptomic and genetic integrative
analysis reveals important roles of adenosine diphosphate in
haemostasis and platelet activation in non-small-cell lung cancer.
Mol Oncol. 13:2406–2421. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu L, Wang H, Wei D, Wang B, Zhang C, Zhu
T, Ma Z, Li Z, Wu Y and Yu G: The value of CEP55 gene as a
diagnostic biomarker and independent prognostic factor in LUAD and
LUSC. PLoS One. 15:e02332832020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li K, Tian Y, Yuan Y, Fan X, Yang M, He Z
and Yang D: Insights into the Functions of lncRNAs in
Drosophila. Int J Mol Sci. 20:202019.
|
|
8
|
Murillo-Maldonado JM and Riesgo-Escovar
JR: The various and shared roles of lncRNAs during development. Dev
Dyn. 248:1059–1069. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu J, Yu W, Wang Y, Xia K, Huang Y, Xu A,
Chen Q, Liu B, Tao H, Li F, et al: lncRNAs: Function and mechanism
in cartilage development, degeneration, and regeneration. Stem Cell
Res Ther. 10:3442019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Jin J, Xu Z and Zuo B: Functions
and Regulatory Mechanisms of lncRNAs in Skeletal Myogenesis, Muscle
Disease and Meat Production. Cells. 8:82019. View Article : Google Scholar
|
|
11
|
Lim LJ, Wong SYS, Huang F, Lim S, Chong
SS, Ooi LL, Kon OL and Lee CG: Roles and Regulation of Long
Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res.
79:5131–5139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long Non-Coding RNA in the Pathogenesis of Cancers. Cells. 8:82019.
View Article : Google Scholar
|
|
13
|
Yang J, Qiu Q, Qian X, Yi J, Jiao Y, Yu M,
Li X, Li J, Mi C, Zhang J, et al: Long noncoding RNA LCAT1
functions as a ceRNA to regulate RAC1 function by sponging
miR-4715-5p in lung cancer. Mol Cancer. 18:1712019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Feng C, Li Y, Ma Y and Cai R:
lncRNA H19 promotes lung cancer proliferation and metastasis by
inhibiting miR-200a function. Mol Cell Biochem. 460:1–8. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang N, Guo W, Ren K, Li W, Jiang Y, Sun
J, Dai W and Zhao W: lncRNA AFAP1-AS1 Supresses miR-139-5p and
Promotes Cell Proliferation and Chemotherapy Resistance of
Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
Front Oncol. 9:11032019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin D, Guo J, Wu Y, Du J, Yang L, Wang X,
Di W, Hu B, An J, Kong L, et al: m6A mRNA methylation initiated by
METTL3 directly promotes YAP translation and increases YAP activity
by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug
resistance and metastasis. J Hematol Oncol. 12:1352019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Zhu J, Xiao Z, Wang X and Luo J:
BBOX1-AS1 contributes to colorectal cancer progression by sponging
hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio. 2211–5463,
12802. 2020.
|
|
18
|
Yang Y, Yu Q, Li B, Guan R, Huang C and
Yang X: BBOX1-AS1 Accelerates Gastric Cancer Proliferation by
Sponging miR-3940-3p to Upregulate BIRC5 Expression. Dig Dis Sci.
66:1054–1062. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Yang B, Wang L, Zhu Y, Zhu X, Xia Z,
Zhao Z and Xu L: lncRNA BBOX1-AS1 upregulates HOXC6 expression
through miR-361-3p and HuR to drive cervical cancer progression.
Cell Prolif. 53:e128232020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi J, Yang C, An J, Hao D, Liu C, Liu J,
Sun J and Jiang J: KLF5-induced BBOX1-AS1 contributes to cell
malignant phenotypes in non-small cell lung cancer via sponging
miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
J Exp Clin Cancer Res. 40:1482021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, He RQ, Dang YW, Zhang XL, Wang X,
Huang SN, Huang WT, Jiang MT, Gan XN, Xie Y, et al: Comprehensive
analysis of the long noncoding RNA HOXA11-AS gene interaction
regulatory network in NSCLC cells. Cancer Cell Int. 16:892016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Linehan WM and Ricketts CJ: The Cancer
Genome Atlas of renal cell carcinoma: Findings and clinical
implications. Nat Rev Urol. 16:539–552. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xia L, Zhang W and Gao L: Clinical and
prognostic effects of CDKN2A, CDKN2B and CDH13 promoter methylation
in ovarian cancer: A study using meta-analysis and TCGA data.
Biomarkers. 24:700–711. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai KT, Liu AG, Wang ZF, Jiang HW, Zeng
JJ, He RQ, Ma J, Chen G and Zhong JC: Expression and potential
molecular mechanisms of miR 204 5p in breast cancer, based on
bioinformatics and a meta analysis of 2,306 cases. Mol Med Rep.
19:1168–1184. 2019.PubMed/NCBI
|
|
25
|
Gan BL, Zhang LJ, Gao L, Ma FC, He RQ,
Chen G, Ma J, Zhong JC and Hu XH: Downregulation of miR 224 5p in
prostate cancer and its relevant molecular mechanism via TCGA, GEO
database and in silico analyses. Oncol Rep. 40:3171–3188.
2018.PubMed/NCBI
|
|
26
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2ˆ(−delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
27
|
Zhang Y, Chen WJ, Gan TQ, Zhang XL, Xie
ZC, Ye ZH, Deng Y, Wang ZF, Cai KT, Li SK, et al: Clinical
Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based
on Bioinformatics, In Vitro and In Vivo Verification. Sci Rep.
7:55672017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Li ZY, Hou XX, Wang X, Luo YH,
Ying YP and Chen G: Clinical significance and effect of AEG-1 on
the proliferation, invasion, and migration of NSCLC: A study based
on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo
verification. Oncotarget. 8:16531–16552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng Q, Huang C, Cao H, Lin J, Gong X, Li
J, Chen Y, Tian Z, Fang Z and Huang J: A Novel Prognostic Signature
of Transcription Factors for the Prediction in Patients With GBM.
Front Genet. 10:9062019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding J and Zhang Y: Analysis of key GO
terms and KEGG pathways associated with carcinogenic chemicals.
Comb Chem High Throughput Screen. Dec 18–2017.(Epub ahead of
print). doi: 10.2174/1386207321666171218120133. PubMed/NCBI
|
|
31
|
Zhou Z, Li Y, Hao H, Wang Y, Zhou Z, Wang
Z and Chu X: Screening Hub Genes as Prognostic Biomarkers of
Hepatocellular Carcinoma by Bioinformatics Analysis. Cell
Transplant. 28 (Suppl 1):76S–86S. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang Y, Zhang C, Ma MH and Dai DQ:
Identification and prediction of novel non-coding and coding
RNA-associated competing endogenous RNA networks in colorectal
cancer. World J Gastroenterol. 24:5259–5270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Sousa VML and Carvalho L: Heterogeneity
in Lung Cancer. Pathobiology. 85:96–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aboubakar Nana F, Vanderputten M and Ocak
S: Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its
Potential as a Therapeutic Target. Cancers (Basel). 11:112019.
View Article : Google Scholar
|
|
35
|
Mughal MJ, Mahadevappa R and Kwok HF: DNA
replication licensing proteins: Saints and sinners in cancer. Semin
Cancer Biol. 58:11–21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yenerall P, Das AK, Wang S, Kollipara RK,
Li LS, Villalobos P, Flaming J, Lin YF, Huffman K, Timmons BC, et
al: RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA
Replication and Radioresistance in Lung Cancer. Cell Chem Biol.
27:105–121.e14. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang L and Zhao L, Bi J, Guan Q, Qi A,
Wei Q, He M, Wei M and Zhao L: Glycolysis gene expression
profilings screen for prognostic risk signature of hepatocellular
carcinoma. Aging (Albany NY). 11:10861–10882. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qi L, Gao C, Feng F, Zhang T, Yao Y, Wang
X, Liu C, Li J, Li J and Sun C: MicroRNAs associated with lung
squamous cell carcinoma: New prognostic biomarkers and therapeutic
targets. J Cell Biochem. 120:18956–18966. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H,
Liang Y, Liu Y, Zhang N and Yang Q: lncRNA-CDC6 promotes breast
cancer progression and function as ceRNA to target CDC6 by sponging
microRNA-215. J Cell Physiol. 234:9105–9117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang SJ and Yang JB: lncRNA SNHG14
aggravates invasion and migration as ceRNA via regulating
miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. Mol Cell
Biochem. 473:143–153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yao H, Chen R, Yang Y and Jiang J: lncRNA
BBOX1-AS1 Aggravates the Development of Ovarian Cancer by
Sequestering miR-361-3p to Augment PODXL Expression. Reprod Sci.
28:736–744. 2021. View Article : Google Scholar : PubMed/NCBI
|
